The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early ...
Analysts said the deal shows Roche’s long-term strategy for its sequencing technology is “a clinical box for running NGS kits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback